Cite
CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway
MLA
Sheng-Chu Kuo, et al. “CWF-145, a Novel Synthetic Quinolone Derivative Exerts Potent Antimitotic Activity against Human Prostate Cancer: Rapamycin Enhances Antimitotic Drug-Induced Apoptosis through the Inhibition of Akt/MTOR Pathway.” Chemico-Biological Interactions, vol. 260, Dec. 2016, pp. 1–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cb8ebd19055047669428431c778e22e&authtype=sso&custid=ns315887.
APA
Sheng-Chu Kuo, Chi-Tang Ho, Tzong Der Way, Ying Chao Lin, Liang Chih Liu, & Chao Ming Hung. (2016). CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway. Chemico-Biological Interactions, 260, 1–12.
Chicago
Sheng-Chu Kuo, Chi-Tang Ho, Tzong Der Way, Ying Chao Lin, Liang Chih Liu, and Chao Ming Hung. 2016. “CWF-145, a Novel Synthetic Quinolone Derivative Exerts Potent Antimitotic Activity against Human Prostate Cancer: Rapamycin Enhances Antimitotic Drug-Induced Apoptosis through the Inhibition of Akt/MTOR Pathway.” Chemico-Biological Interactions 260 (December): 1–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cb8ebd19055047669428431c778e22e&authtype=sso&custid=ns315887.